63%) were female and 66 (38.37%) were male. Most of the HIV-infected patients belonged to Small molecule library chemical structure Centers for Disease Control and Prevention (CDC) categories B (43.02%) and C (30.23%). Most of the HIV-positive patients (68.60%) had CD4 counts<200 cells/μL (Table 2).

According to the CDC criteria [24], OIs were observed in 102 HIV-positive patients while 70 were asymptomatic. One hundred and two HIV-positive patients had experienced at least one AIDS event based on the occurrence of OIs (tuberculosis in 48 cases, pneumocystosis in 29 cases, toxoplasmosis in eight cases, cytomegalovirus infection in four cases, cryptococcosis in 17 cases, Kaposi sarcoma in 12 cases and prurigo in 22 cases). HIV-positive patients had significantly higher TG values (P<0.0001) and atherogenicity index (P<0.001) and significantly lower TC, HDLC and LDLC values (P=0.006, 0.0001 and 0.012, respectively) compared with controls (Table 3). HIV-positive patients had a significantly (P<0.0001) higher prevalence of hypertriglyceridaemia, TC hypocholesterolaemia, HDLC hypocholesterolaemia and LDLC hypocholesterolaemia compared with controls. The prevalence of hypotriglyceridaemia, TC hypercholesterolaemia, HDLC hypercholesterolaemia and LDLC hypercholesterolaemia was higher in HIV-positive patients compared with controls, but the difference was not significant (Table 4). Compared with the controls, TG was significantly

higher buy ICG-001 in patients in group 1 (P<0.0001), group 2 (P<0.001) and group 3 (P=0.003). The atherogenicity index was significantly higher in patients in groups 1, 3 and 4 (patients with CD4 counts>350 cells/μL) (P<0.0001), while TC was significantly lower in group 1 (P<0.0001) and group 2 (P<0.001). LDLC levels were significantly lower in patients in group 1 (P<0.0001) and HDLC levels were significantly

lower in all groups of patients (groups 1, 2, 3 and 4) (Table 5). Lipid and nutritional status results for 102 patients with active OIs or malignancies were compared with those for 70 patients with no OIs. Those with OIs had significantly lower TC (P=0.002) and HDLC (P=0.005) than those with no OIs, while their atherogenicity index was significantly higher. TG (227.86±36.25 mg/dL) and LDLC (99.98±62.32 mg/dL) were significantly higher (P<0.01) Methocarbamol in patients with OIs than in patients without OIs (TG=205.81±23.54 mg/dL; LDLC=83.32±80.11 mg/dL). BMI was lower in patients with OIs (21.89±3.52 kg/m2) than in patients without OIs (23.62±4.32 kg/m2) but the difference was not significant (P=0.3) (Table 6). High TG values were associated or correlated with CD4 count<50 cells/μL (r=0.612, P=0.002) (group 1), with CD4 count between 50 and 200 cells/μL (r=0.601, P=0.002) (group 2) and with the occurrence of OIs (r=0.532, P=0.003). HDLC also correlated positively with CD4 count<50cells/μL (r=0.521, P=0.008), with CD4 count between 50 and 200 cells/μL (r=0.542; P=0.007) and with the occurrence of OIs (r=0.618, P=0.002).